This Death Row Inmate’s Blood-Filled Tumors Could Make His Execution Especially Cruel and Unusual

Russell Bucklew suffers from a rare disease.

Missouri's death chamberJames A. Finley/AP

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Missouri death row inmate Russell Bucklew is scheduled to die on Tuesday. But Bucklew suffers from a rare medical condition, and his lawyers say the execution drug that will be used could come with gruesome consequences and constitute cruel and unusual punishment.

For nearly all his life, Bucklew has been afflicted with cavernous hemangioma, a rare disease that causes tumors to form in his face, head, neck, and throat. Prison staff intend to use pentobarbital, a sedative, to execute him, but this could cause his tumors to burst. Cheryl Pilate, one of Bucklew’s lawyers told the Associated Press on Monday, he would likely experience “a gruesome execution with choking and gagging on blood and the infliction of excruciating pain.” 

Bucklew, who is 49 years old, has been on death row for more than 20 years for the 1996 murder of Michael Sanders in Cape Giradeau, Missouri. Sanders was the new boyfriend of Bucklew’s former girlfriend Stephanie Ray. Bucklew shot Sanders in front of his children, Ray, and her children and then kidnapped Ray and took her to a secluded area. After raping her, he drove her to the St. Louis area as a hostage where a high-speed chase and shootout with a state trooper ensued. Bucklew was arrested and held in the Cape Girardeau County jail but escaped a few months later in June by hiding in a trash can that was taken out of the prison. While on the run, he went to the home of Ray’s mother and attacked her with a hammer, but she survived. Two days later, Bucklew was apprehended and jailed. In 1997, he was convicted of kidnap, rape, and murder, and sentenced to death.

Missouri first attempted to execute Bucklew in May 2014, but the US Supreme Court granted a stay in order to allow Bucklew’s claims that his execution would be painful to work its way through the lower courts. Bucklew’s lawyers argued that given his illness, he could not be humanely executed, and this cruel and unusual punishment would be a violation of the Eighth Amendment. In Glossip v. Gross, the US Supreme Court said that when the Eighth Amendment is used to challenge a method of execution a “reasonable alternative” must be proposed by the inmate. 

In the 2014 appeal, Bucklew’s lawyers suggested that the state use nitrogen gas to execute him. (The state of Oklahoma recently proposed it as an alternative to lethal injection.) According to court documents, Dr. Joel Zivot, a professor of surgery and anesthesiology at Emory University said that “substantial risk” exists that Bucklew will “suffer from extreme or excruciating pain.” But last June, a federal judge ruled that because Bucklew could not actually show that death by nitrogen would reduce the risk of suffering, his execution should proceed.  

Missouri uses a one-drug protocol in its executions in which death row inmates are injected with a large dose of the sedative pentobarbital. According to a Buzzfeed News report, the state’s drug supplier is a pharmacy with a history of selling contaminated drugs, and anti-death penalty advocates argue that contaminated pentobarbital would also cause a painful death for Bucklew.

Last week, in the appeal Bucklew’s lawyers filed with the US Supreme Court, they asked for the court to spare his life and painted a grim picture of what could happen during the execution. “As he struggles to breathe through the execution procedure,” they wrote, “Bucklew’s throat tumor will likely rupture…filling his mouth and airway with blood, causing him to choke and cough on his own blood.”

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

AN IMPORTANT UPDATE ON MOTHER JONES' FINANCES

We need to start being more upfront about how hard it is keeping a newsroom like Mother Jones afloat these days.

Because it is, and because we're fresh off finishing a fiscal year, on June 30, that came up a bit short of where we needed to be. And this next one simply has to be a year of growth—particularly for donations from online readers to help counter the brutal economics of journalism right now.

Straight up: We need this pitch, what you're reading right now, to start earning significantly more donations than normal. We need people who care enough about Mother Jones’ journalism to be reading a blurb like this to decide to pitch in and support it if you can right now.

Urgent, for sure. But it's not all doom and gloom!

Because over the challenging last year, and thanks to feedback from readers, we've started to see a better way to go about asking you to support our work: Level-headedly communicating the urgency of hitting our fundraising goals, being transparent about our finances, challenges, and opportunities, and explaining how being funded primarily by donations big and small, from ordinary (and extraordinary!) people like you, is the thing that lets us do the type of journalism you look to Mother Jones for—that is so very much needed right now.

And it's really been resonating with folks! Thankfully. Because corporations, powerful people with deep pockets, and market forces will never sustain the type of journalism Mother Jones exists to do. Only people like you will.

There's more about our finances in "News Never Pays," or "It's Not a Crisis. This Is the New Normal," and we'll have details about the year ahead for you soon. But we already know this: The fundraising for our next deadline, $350,000 by the time September 30 rolls around, has to start now, and it has to be stronger than normal so that we don't fall behind and risk coming up short again.

Please consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

—Monika Bauerlein, CEO, and Brian Hiatt, Online Membership Director

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate